Modulation of bovine leukemia virus-associated spontaneous lymphocyte proliferation by monoclonal antibodies to lymphocyte surface molecules

Clinical Immunology and Immunopathology

Volumn 83, Issue 2, 1997, Pages 156-164

  Stone, Diana M ^a   Norton, Linda K ^a   Davis, William C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CELL ADHESION MOLECULE; INTEGRIN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; BOVINE LEUKEMIA VIRUS; CONTROLLED STUDY; COW; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030907688     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4340     Document Type: Article

References (45)

1. Sagata N., Yasanuga T., Tsuzuku-Kawamura J., Ohihi K., Ogawa Y., Ihawa I. Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. USA. 82:1985;677-682.
2. Ciminale V., Pavlakis G. N. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J. Virol. 66:1992;1737-1745.
3. Hollsberg P., Hafler D. A. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1993;1173-1182.
4. Kim J. H., Durack D. T. Manifestations of human T-lymphotropic virus type I infection. Am. J. Med. 84:1988;919-928.
5. Mchizuki M., Watanabe K., Yamaguchi K. Uveitis associated with human T lymphotropic virus type I: Seroepidemiologic, clinical, and virologic studies. J. Infect. Dis. 166:1992;943-944.
6. Posenblatt J. D., Chen I. S. Y., Wachsman W. Infection with HTLV-I and HTLV-II: Evolving concepts. Semin. Hematol. 25:1988;230-246.
7. Depelchin A., Letesson J. J., Lostrie-Trussart N., Mammerickx M., Portetelle D., Burny A. Bovine leukemia virus (BLV)-infected B-cells express a marker similar to the CD5 T cell marker. Immunol. Lett. 20:1989;69-76.
8. Burny A., Bruck C., Cleuter Y., Couez D., Deschamps J., Ghysdael J., Bregoire D., Kettmann R., Mammerickx M., Marbaix G., Portetelle D. Bovine Leukemia Virus: A New Mode of Leukemogenesis. 1985;Raven Press, New York. p. 35-55.
9. Itoyama Y., Minato S., Kira J., Goto I., Sato H., Okochi K., Yamamoto N. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 38:1988;1302-1307.
10. Prince H. E., Lee H., Jensen E. R., Swanson P., Weber D., Fitzpatrick L., Doyle M., Kleinman S. Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection. Blood. 78:1991;169-174.
11. Prince H. E., Weber D. M., Jensen E. R. Spontaneous lymphocyte proliferation in HTLV-I/II infection reflects preferential activation of CD8 and CD16/56 cell subsets. Clin. Immunol. Immunopathol. 58:1991;419-430.
12. Lal R. B., Hjelle B., Rudolph D. L., Spontaneous proliferation of HTLV-II-infected peripheral blood lymphocytes: HLA-DR-driven IL-. 2-dependent response. Microbiol. Immunol. 36:1992;865-872.
13. Muscoplat C. C., Alhaji I., Johnson D. W., Pomeroy K. A., Olson J. M., Larson V. L., Stevens J. B., Sorensen D. K. Characteristics of lymphocyte responses to phytomitogens: Comparison of responses of lymphocytes from normal and lymphotropic cows. Am. J. Vet. Res. 35:1974;1053-1055.
14. Weiland F., Straub O. C. Differences in thein vitro. Res. Vet. Sci. 20:1976;340-341.
15. Thorn R. M., Gupta P., Kenyon S. J., Ferrer J. F. Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific. Infect. Immun. 34:1981;84-89.
16. Mann D. L., Martin P., Hamlin-Green G., Nalewaik R., Blattner W. Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. Clin. Immunol. Immunopathol. 3:1994;312-320.
17. Prince H. E., Golding J., York J. Lymphocyte subset alterations associated with increased spontaneous lymphocyte proliferation in human T lymphotropic virus (HTLV) infection: Distinctive patterns for HTLV-I versus HTLV-II infection. J. Infect. Dis. 169:1994;1409-1410.
18. Dezzutti C. S., Rudolph D. L., Shawan S., Lal R. B. Modulation of HTVL-II associated spontaneous lymphocyte proliferation by β2 integrin CD11a/CD18 involves interaction with its cognate ligand, CD54. Cell. Immunol. 156:1994;113-123.
19. Lal R. B., Rudolph D. L., Rowe T., Folks T. M. Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals. J. Clin. Immunol. 12:1992;75-83.
20. Tanaka Y., Oda S., Nagata K., Mori N., Sakamoto H., Eto S., Yamashita U. Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers. J. Clin. Immunol. 9:1989;477-484.
21. Prince H. E., York J., Golding J., Owen S. M., Lal R. B. Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T cell subset responses and their relationships to the presence or provirus and viral antigen production. Clin. Diag. Lab. Immunol. 1:1994;273-282.
22. Jacobson S., Zaninovic V., Mora C. Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis. Ann. Neurol. 23:1988;S192-S200.
23. Itoyama Y., Kira K., Fuji N., Goto I., Yamamoto N. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy. Ann. Neurol. 26:1989;257-262.
24. Eiraku N., Ijichi S., Yashiki S., Osame M., Sonoda S. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP). J. Neuroimmunol. 37:1992;223-228.
25. Prince H. E., Jensen E. R., York J. Lymphocyte subsets in HTLV-II-infected former blood donors: Relationship to spontaneous lymphocyte proliferation. Clin. Immunol. Immunopathol. 65:1992;201-206.
26. Stone D. M., McElwain T. F., Davis W. C. Enhanced B-lymphocyte expression of IL-2Rα associated with T lymphocytosis in BLV-infected persistently lymphocytotic cows. Leukemia. 6:1994;1057-1061.
27. Stone D. M., Hof A. J., Davis W. C. Up-regulation of IL-2 receptor α and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet. Immunol. Immunopathol. 48:1995;65-76.
28. Bendixen H. J. Bovine enzootic leukosis. Adv. Vet. Sci. 10:1965;129-203.
29. Davis W. C., Oarsen R. A., Monagham M. L. Genetic markers identified by immunogenetic methods. Am. Fish. Soc. Symp. 7:1990;521-540.
30. Davis W. C., Hamilton M. J., Park Y., Larsen R. A., Wyatt C. R., Okada K. Ruminant leukocyte differentiation molecules. Barta O. MHC Differentiation Antigens, and Cytokines in Animals and Birds. Monographs in Animal Immunology. 1990;47-70 BAR-Lab, Inc. Blacksburg.
31. Naessens J., Sileghem M., NacHugh N., Park Y. H., Davis W. C., Toye P. Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene. Immunology. 76:1992;305-309.
32. Davis W. C., MacHugh N. D., Park Y., Hamilton M. J., Wyatt C. R. Identification of a monoclonal antibody reactive with the bovine orthologue of CD3 (BoCD3). Vet. Immunol. Immunopathol. 39:1993;85-91.
33. Ababou A., Goyeneche J., Davis W. C., Levy D. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: Determination of a non-DR non-DQ gene product. J. Leukocyte Biol. 56:1994;182-186.
34. Young I. T. Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25:1977;935-941.
35. Kishimoto T. K., Larson R. S., Corbi A. L., Dustin M. L., Staunton D. E., Springer T. A. The leukeocyte integrins: LFA-1, Mac-1, and p150,95. Adv. Immunol. 46:1989;149-182.
36. +. Leukemia. 6:1992;304-309.
37. Schwarting R., Stein H., Wang C. Y. The monoclonal antibodies αS-HCL 1 (αLeu-14) and αS-HCL 3 (αLeu-M5) allow the diagnosis of hairy cell leukemia. Blood. 65:1985;974-983.
38. Springer R. A., Miller L. J., Anderson D. C. p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J. Immunol. 136:1986;240-245.
39. Miller L. J., Schwarting R., Springer T. A. Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation. J. Immunol. 137:1986;2891-2900.
40. Keizer G. D., te Velda A. A., Scharting R., Figdor C. G., de Vries J. I. Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur. J. Immunol. 17:1987;1317-1322.
41. +. Eur. J. Immunol. 18:1988;1131-1134.
42. Mirsky M. L., Da Y., Lewin H. A. Detection of bovine leukemia virus proviral DNA in individual cells. PCR Methods Appl. 2:1993;333-340.
43. Jensen W. A., Rovnak J., Cockerell G. L. In vivo transcription of the bovine leukemia virustaxrex. J. Virol. 65:1991;2484-2490.
44. Haas L., Divers T., Casey J. W. Bovine leukemia virus gene expression in vivo. J. Virol. 66:1992;6223-6226.
45. Lal R. B., Rudolph D. L., Dezzutti C. S., Linsley P. S., Prince H. E. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands. J. Immunol. 157:1996;1288-1296.